Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas. (Q39707882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Sebastián Giulianelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Victoria Wargon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sandra V Fernandez

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Mercedes Goin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Jose Russo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Claudia Lanari

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

English

0 references

publication date

4 May 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

319-332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20440553%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-010-0908-x

1 February 2020

exact match

0 references

cites work

Endocrine treatment of breast cancer in women

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Therapeutic strategies using the aromatase inhibitor letrozole and tamoxifen in a breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Induction of mammary adenocarcinomas by medroxyprogesterone acetate in BALB/c female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

The MPA mouse breast cancer model: evidence for a role of progesterone receptors in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Progesterone receptor expression in medroxyprogesterone acetate-induced murine mammary carcinomas and response to endocrine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

DNA methylation and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

ER re-expression and re-sensitization to endocrine therapies in ER-negative breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Morphological evaluation of cell turnover in relation to the menstrual cycle in the “resting” human breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

CpG-rich islands and the function of DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

The loss of estrogen and progesterone receptor gene expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

DNA methylation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

p21, p27 and p53 in estrogen and antiprogestin-induced tumor regression of experimental mouse mammary ductal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Nucleic acid sequence and DNase hypersensitive sites of the 5' region of the mouse progesterone receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Demethylation of the progesterone receptor CpG island is not required for progesterone receptor gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

ER alpha negative breast cancer cells restore response to endocrine therapy by combination treatment with both HDAC inhibitor and DNMT inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Mammary carcinogenesis induced by N-methyl-N-nitrosourea (MNU) and medroxyprogesterone acetate (MPA) in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Novel mechanisms of antiprogestin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

A rationale for inhibiting progesterone-related pathways to combat breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Antisense oligonucleotides targeting the progesterone receptor inhibit hormone-independent breast cancer growth in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

DNA methyltransferase inhibitors and the development of epigenetic cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Resistance to endocrine therapy: are breast cancer stem cells the culprits?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X

Breast cancer-associated fibroblasts confer AKT1-mediated epigenetic silencing of Cystatin M in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-010-0908-X